According to the Zhitong Finance App, Global Healthcare (02666) announced its 2026 interim results, with revenue of about 7.1 billion yuan, a year-on-year decrease of 6.3%. Profit attributable to the company's common equity holders was about 1,262.5 billion yuan, an increase of 2.8% over the previous year. Profit per share was $0.63.
In the first half of 2026, the comprehensive medical sector combined 65 medical institutions (including 5 top 3 hospitals, 1 level-III specialist hospital, and 30 level-II hospitals), with a total number of open beds of 15,301, contributing about 3.839 billion yuan in reporting revenue, a year-on-year decrease of 9.1%; profit during the realized period was 176.5 billion yuan, a year-on-year decrease of 23.6%. This decline is mainly due to two factors. First, reforms in the medical and health care industry have continued to deepen, and changes in the external environment have brought structural operating pressure; second, the commissioning of new infrastructure projects since 2024 has increased the scale of operation of medical institutions, leading to an increase in depreciation and amortization and labor costs.
In the first half of 2026, the group accelerated the transformation and upgrading of financial business while strengthening cost control. The total revenue achieved was about 2,496 billion yuan, a year-on-year decrease of 12.5%; profit during the realized period was 1,095 billion yuan, an increase of 4.3% over the previous year. The average return on interest-bearing assets was 6.86%, down 0.36 percentage points; the average cost ratio of interest-bearing debt was 3.01%, down 0.39 percentage points; the net interest spread was 3.85%, up 0.03 percentage points year on year, and the net interest spread was 4.42%, up 0.08 percentage points year on year.